Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes

Background Inactivated alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are related to esophageal carcinogenesis. We aimed to clarify the clinical features associated with the alcohol-degrading enzyme genotypes, ADH1B and ALDH2 . We also investigated the risk factors for metachronous esophageal squamous cell carcinoma (ESCC) and head and neck SCC (HNSCC). Methods We conducted a single-center, retrospective study including patients with ESCC treated by endoscopic resection. Patients were recruited between October 2020 and September 2021. Buccal mucosal swabs were obtained from them to analyze the genetic polymorphisms affecting ADH ( ADH1B ) and ALDH ( ALDH2 ) activity. Patients were categorized into three groups: both inactivated = double-inactivated group; inactivated ADH1B or ALDH2 = single-inactivated group; and both activated = activated group. Results Among the 297 enrolled patients, patients in the double-inactivated group were significantly younger ( P < 0.001) and 60% of them were ≤ 50 years old. This group also had more ESCCs located in the upper esophagus ( P < 0.001) and more simultaneous multiple ESCCs ( P = 0.044). More than half of the patients had multiple Lugol-voiding lesions (LVLs) ( P < 0.001) and heavy alcohol consumers ( P = 0.012). Metachronous ESCC and HNSCC were more common in the double-inactivated group ( P < 0.001, P = 0.001). Multivariate analysis identified located in the upper esophagus, multiple LVLs and history of HNSCC as risk factors for metachronous ESCC. Conclusions Activation patterns of alcohol-metabolizing enzymes were related to age at ESCC onset, lesion location, and metachronous ESCC and HNSCC. Different approaches to the prophylaxis and treatment of esophageal cancer should be considered, depending on the enzyme activity pattern.